HDAC7 Gene

HDAC7 Gene

Overview

HDAC7 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HDAC7 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HDAC7</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HDAC7</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=HDAC7" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">120 edges</a></td>
</tr>
</table>

HDAC7 encodes histone deacetylase 7, a class IIa histone deacetylase that primarily acts as a signal-responsive transcriptional coregulator rather than a high-turnover catalytic deacetylase. In practical terms, HDAC7 helps translate extracellular signaling into durable transcriptional state changes by partnering with tissue-specific transcription factors and chromatin complexes["@wang2026"][@kutil2025].

For neurodegeneration research, HDAC7 is relevant in three layers:

• Epigenetic state control: HDAC7 participates in chromatin programs that can alter neuronal stress responses.
• Cell-state coupling: class IIa HDACs shuttle between nucleus and cytoplasm in response to kinase signaling, linking activity state to gene expression programs.
• Therapeutic tractability: the broader [HDAC](/entities/hdac-enzymes) inhibitor field is clinically advanced, making HDAC7-containing complexes an attractive precision-targeting problem.

Gene And Protein Features

HDAC7 is located on chromosome 12q13 and belongs to the vertebrate class IIa HDAC subgroup (with HDAC4, HDAC5, and HDAC9). Major functional design elements include:

• A large N-terminal regulatory scaffold with protein-protein interaction motifs.
• A C-terminal deacetylase-like domain with relatively low intrinsic catalytic activity compared with class I HDACs.
• Phosphorylation-dependent nuclear export/import behavior controlled by upstream kinases and 14-3-3 interactions.

Role In Neural And Glial Regulation

Direct HDAC7-specific mechanistic mapping in adult neurodegeneration remains less mature than for HDAC1/2/3/6, but several principles are actionable:

Neurodegeneration Relevance

Alzheimer's And Parkinsonian Disorders

AD and parkinsonian syndromes exhibit epigenetic dysregulation across [neurons](/entities/neurons) and glia. HDAC-focused reviews continue to identify deacetylase pathways as plausible intervention points for synaptic dysfunction, neuroinflammation, and stress-induced transcriptional collapse[@kanwal2022][@li2025].

Huntington's Disease And Polyglutamine Disorders

Polyglutamine model systems have shown phenotype improvement with selective HDAC-targeting approaches, supporting an epigenetic strategy in proteotoxic disorders[@jia2012]. While those results are not HDAC7-specific, they strengthen the class-level argument for mechanistically selective deacetylase intervention.

Retinal And Visual Neurodegeneration

Experimental models of excitotoxic retinal ganglion cell injury demonstrate contribution of HDAC pathways to neurodegeneration, again supporting the broader concept that HDAC-axis modulation can influence neuronal survival trajectories[@pelzel2019].

Therapeutic Targeting Strategy

A high-quality HDAC7 strategy should avoid blunt pan-HDAC inhibition whenever possible. Priorities include:

• Isoform-aware design: define HDAC7-dependent transcriptional modules in disease-relevant cell types.
• Scaffold biology: target recruitment interfaces and complex assembly where HDAC7 acts as a platform.
• Context gating: identify disease stages where HDAC7 modulation is protective versus potentially disruptive.
• Combination logic: pair epigenetic modulation with therapies that reduce upstream stress burden.

Biomarker And Experimental Readouts

Useful HDAC7-axis development readouts include:

• Isoform-resolved HDAC expression panels in disease-relevant tissues.
• Chromatin accessibility and histone-acetylation signatures paired with cell-type deconvolution.
• Transcriptomic reversal metrics for disease-specific maladaptive gene programs.
• Functional outcomes tied to synaptic physiology and neuroinflammation markers.

Evidence Gaps

Key unresolved questions for HDAC7 in neurodegeneration:

Answering these requires isoform-specific perturbation studies, longitudinal tissue atlases, and mechanism-first trial designs.

See Also

• [HDAC7 Protein](/proteins/hdac7-protein)
• [Chromatin Remodeling in Neurodegeneration](/mechanisms/chromatin-remodeling-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: hdac7](https://www.ncbi.nlm.nih.gov/gene/)
• [PubMed: hdac7](https://pubmed.ncbi.nlm.nih.gov/?term=hdac7+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving HDAC7 Gene discovered through SciDEX knowledge graph analysis: